Artificial Embolization Device Downclassification Supported By Panel
This article was originally published in The Gray Sheet
Executive Summary
Artificial embolization devices for neurological use should be downclassified to Class II, FDA's Neurological Devices Panel agreed at a June 12 meeting in Rockville, Maryland.